Evaluating the effect of prior authorizations in patients with complex dermatologic conditions

Abstract

In dermatology, prior authorizations can delay treatment, decrease patient adherence, and deter providers from advocating for their patients. Patients with complex dermatologic conditions, often requiring off-label treatments, may face particularly significant insurance barriers. Evaluate the effect of prior authorizations in patients with complex dermatologic conditions. This prospective cohort study assessed patients treated by a dermatologist during 5months who specialized in complex dermatology. Patients included were older than 18years, treated at V.P.W.'s rheumatology-dermatology clinic, and prescribed a medication or ordered a diagnostic procedure that elicited an insurance prior authorization. Data on prior authorization outcome, administrative time, and delay to treatment were collected. Of 51 prior authorizations, 51% were initially denied, with systemic medications more likely denied than topical ones (P<.001). Total administrative time spent on 50 prior authorizations tracked was 62.5hours (median time per prior authorization 30minutes [interquartile range 17-105minutes]). Time to access treatment was tracked for 80% of prior authorizations; median delay was 12days [interquartile range 5.5-23days]. Single-center, single-provider patient panel. Patients with complex dermatologic conditions face a significant barrier to care because of prior authorizations. The administrative burden for provider practices to address these prior authorizations is substantial and may warrant a streamlined system in collaboration with insurers.